Alphatec Holdings Inc (ATEC) Shares Bought by Armistice Capital LLC

Armistice Capital LLC boosted its holdings in Alphatec Holdings Inc (NASDAQ:ATEC) by 18.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 778,414 shares of the medical technology company’s stock after purchasing an additional 120,000 shares during the period. Armistice Capital LLC’s holdings in Alphatec were worth $2,071,000 as of its most recent SEC filing.

Separately, Broadfin Capital LLC purchased a new position in Alphatec in the fourth quarter worth $387,000. 18.25% of the stock is owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

Alphatec Holdings Inc (NASDAQ:ATEC) opened at $3.43 on Friday. The company has a debt-to-equity ratio of -1.11, a current ratio of 2.11 and a quick ratio of 1.08. Alphatec Holdings Inc has a 1 year low of $1.58 and a 1 year high of $4.27. The firm has a market capitalization of $56.86, a price-to-earnings ratio of -2.12 and a beta of 1.43.

Several research analysts have weighed in on ATEC shares. ValuEngine cut Alphatec from a “sell” rating to a “strong sell” rating in a research report on Friday, December 1st. Zacks Investment Research raised Alphatec from a “sell” rating to a “hold” rating in a research report on Tuesday, January 23rd. Finally, HC Wainwright reissued a “buy” rating and issued a $4.00 price objective on shares of Alphatec in a research report on Wednesday, November 22nd.

COPYRIGHT VIOLATION NOTICE: “Alphatec Holdings Inc (ATEC) Shares Bought by Armistice Capital LLC” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at

About Alphatec

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Want to see what other hedge funds are holding ATEC? Visit to get the latest 13F filings and insider trades for Alphatec Holdings Inc (NASDAQ:ATEC).

Institutional Ownership by Quarter for Alphatec (NASDAQ:ATEC)

Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with's FREE daily email newsletter.

Leave a Reply